Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects with Idiopathic Pulmonary Fibrosis (IPF)
Active
$433.9K Funding
1 People
External
Related Topics
pulmonary fibrosis,
clinical trial,
efficacy,
safety,
treatment
People
Bhupinder Natt
Principal Investigator (PI)
Medicine
﹒Associate Professor, Medicine - (Clinical Scholar Track)
